FILTRIX Logo FILTRIX Find Your Edge →
Ticker Report — Active Last signal ·

$ENTX

Trade-Ideas alerts 61.5% at EOD n=13 2022-01-04 → 2026-07-28

⚠ SMALL SAMPLE · 13 alerts only. Statistics may have high variance — interpret with caution.

🏢 Company Profile

📍 NASDAQ 📅 IPO: Jun 28, 2018 🔗 www.enterabio.com
💰 Market Cap: $495.2M 👥 Employees: 22
Entera Bio Ltd is a clinical-stage biopharmaceutical company engaged in the development of orally delivered macromolecule therapeutics, including peptides and therapeutic proteins. The company focuses on underserved, chronic medical conditions where oral administration of a mini tablet peptide or peptide replacement therapy has the potential to perform. Its product candidates are: EB613, which is being developed as an oral, osteoanabolic (bone-building) tablet treatment for osteoporosis; EB612, being developed as an oral PTH(1-34) tablet peptide replacement therapy for patients with hypoparathyroidism; EB618, an Oral GLP-1 being developed to tackle obesity; and Oral GLP-2, a peptide tablet alternative for patients suffering from short bowel syndrome. The company operates in Israel.
Total alerts
13
Trade-Ideas signal history
Win rate · EOD
61.5%
Best timeframe baseline
Avg gain · EOD
+5.95%
Per-alert expectancy
Avg MFE
+21.68%
Max potential excursion

Practice trading ENTX on historical setups — browse all patterns across all tickers →

📈 Performance by Timeframe

5MIN

Win Rate: 23.1%
Avg Gain: -1.91%
Avg Winner: +2.43%
Avg Loser: -3.21%
Best: +3.63%
Worst: -6.02%
Trades: 3/10

15MIN

Win Rate: 23.1%
Avg Gain: -2.69%
Avg Winner: +3.38%
Avg Loser: -5.63%
Best: +6.25%
Worst: -12.68%
Trades: 3/8

30MIN

Win Rate: 46.2%
Avg Gain: -0.62%
Avg Winner: +6.13%
Avg Loser: -6.40%
Best: +12.08%
Worst: -12.39%
Trades: 6/7

60MIN

Win Rate: 50.0%
Avg Gain: +2.19%
Avg Winner: +11.34%
Avg Loser: -6.97%
Best: +19.05%
Worst: -10.88%
Trades: 6/6

EOD (End of Day)

Win Rate: 61.5%
Avg Gain: +5.95%
Avg Winner: +15.47%
Avg Loser: -9.28%
Best: +30.71%
Worst: -16.52%
Trades: 8/5

🚀 Max Favorable / Adverse Excursion (MFE/MAE)

Institutional-grade metrics showing the maximum profit potential and risk for each alert.

📈 MFE (Max Profit Potential)

Average MFE: +21.68%
Best MFE: +118.89%
Avg Time to MFE: 138 min

On average, ENTX alerts reach +21.68% profit potential within 138 minutes.

📉 MAE (Max Drawdown Risk)

Average MAE: -4.23%
Worst MAE: -11.43%
Avg Time to MAE: 7 min

Before reaching MFE, expect an average drawdown of 4.23%.

⚖️ Risk/Reward Ratio

5.12:1

Excellent risk/reward - potential gain is 5.12x the typical drawdown.

💡 Trading Insight: Based on 13 alerts, ENTX typically reaches +21.68% profit before pulling back. Consider setting profit targets around 17.3% to capture most of the move.

🌅 Premarket Gap Analysis (9:25 → 9:30)

Total Gaps Analyzed 13
Gap Up % 38.5%
Avg Gap -0.06%
Best Gap +10.74%

🏭 Sector Comparison: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)

How ENTX compares to 144 other tickers in the same sector.

5-Min Gain
ENTX: -1.71% Sector: -0.29% -1.43%
EOD Gain
ENTX: +6.92% Sector: +750.04% -743.12%
Avg MFE
ENTX: +23.01% Sector: +6.58% +16.44%

📋 Last 20 Alerts

Historical ENTX alerts with performance metrics calculated from 1-minute price data. Each row shows the actual price movement at different timeframes after the alert.

Date Time Price 5min 15min 30min 60min EOD MFE MAE Gap Result
2026-07-28 09:25:00 $3.9 -3.71% -12.68% -9.60% -10.88% -16.52% +1.49% -4.99% -0.13% LOSS
2026-07-27 09:25:00 $3.0 -5.30% -2.02% +7.37% +19.05% +30.71% +40.05% -7.63% -1.30% LOSS
2026-06-23 09:25:00 $1.34 -0.75% +0.00% +5.22% +16.43% +15.67% +19.40% -4.33% +1.49% LOSS
2026-06-22 09:25:00 $1.27 -3.15% +0.79% +7.76% +13.39% +16.54% +118.89% -3.94% -2.36% LOSS
2026-04-02 09:25:00 $1.2 -2.08% +6.25% +12.08% +6.25% +5.00% +15.83% -2.50% -0.83% LOSS
2026-02-11 09:25:00 $1.55 +1.94% -2.58% -0.05% -0.97% +5.81% +7.10% -3.23% -3.23% WIN
2026-02-09 09:25:00 $1.15 -6.02% +3.11% -2.55% -1.51% +15.72% +22.68% -6.90% -6.90% LOSS
2023-09-12 09:29:00 $0.7 -4.29% -8.21% -8.30% - -5.70% +5.70% -11.43% +0.00% LOSS
2023-03-07 09:27:00 $1.36 -0.74% +0.00% -2.95% -8.83% -9.56% +4.41% +0.74% +1.47% LOSS
2023-03-06 09:26:00 $1.16 +1.72% -2.58% +3.45% +12.07% +24.14% +27.59% -8.62% -2.59% WIN
2022-11-16 09:25:00 $0.56 +3.63% -2.65% +0.87% +0.89% +10.18% +12.39% -4.23% +10.74% WIN
2022-10-06 09:25:00 $1.11 -0.90% -8.56% -12.39% -10.13% -5.41% +2.70% +0.00% +1.80% LOSS
2022-01-04 09:25:00 $3.47 -5.19% -5.76% -8.93% -9.51% -9.22% +3.63% +2.02% +1.06% LOSS

Table Metrics Explained:

  • 5min/15min/30min/60min/EOD: Price change at each timeframe (calculated from real minute-by-minute data)
  • MFE: Maximum Favorable Excursion - highest profit potential reached during the day
  • MAE: Maximum Adverse Excursion - worst drawdown experienced before reaching MFE
  • Gap: Premarket price gap from 9:25 AM to 9:30 AM market open
  • Result: WIN if 5min change > 0%, LOSS otherwise

Beat the 61.5% Baseline on ENTX

The 61.5% win rate is just the raw starting point. Launch the app to apply filters (Volume, RSI, Time) and push ENTX's performance to 75%+.

Optimize ENTX Strategy →

Why Analyze ENTX with FILTRIX?

🛡️ Realistic Entry Simulation

We don't inflate stats. Our analysis tracks only the first alert of the day for ENTX. This simulates a true "Gap & Go" entry at pre-market hours (9:25-9:30 AM), avoiding the trap of chasing a stock that has already extended.

💰 Max Potential (MFE) Analysis

How much is left in the move? On winning days, ENTX historically offers an average upside of +21.68% intraday. Our data helps you distinguish between a quick scalp and a runner.

📊 ENTX Momentum Personality

With a baseline win rate of 61.5%, ENTX shows strong follow-through, making it a prime candidate for momentum strategies.

⏱️ Optimized Exit Timing

Don't guess when to sell. Our backtests show ENTX performs best on the EOD (End of Day) timeframe (Avg Gain: +5.95%), signaling that gains often fade later in the session.